• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NeuroCog Trials receives $1.2M NIMH grant

NeuroCog Trials receives $1.2M NIMH grant

October 1, 2012
CenterWatch Staff

NeuroCog Trials, a Durham, N.C.-based cognitive services provider for the clinical trials industry, has received a 2012 phase II grant from the Small Business Innovation Research (SBIR) program from the National Institute of Mental Health (NIMH), for the validation and commercialization of its Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

NeuroCog Trials had already successfully completed phase I of this project involving the development of the VRFCAT in collaboration with Virtual Heroes, a division of Applied Research Associates.

"Following our early success with the VRFCAT, we set out to secure additional funding to support its validation and commercialization. We aim for the VRFCAT to be used as a reliable tool in clinical trials to measure changes in functional capacity associated with the pro-cognitive effects of novel drugs for schizophrenia, bipolar disorder, Alzheimer's disease and other diseases,” said Richard Keefe, founder and CEO of NeuroCog Trials.

The VRFCAT is a novel virtual reality measure that assesses patients' ability to navigate a variety of daily challenges using realistic, simulated environments.

"The VRFCAT fits into our strategic growth plan involving the development of a cutting edge computerized assessment tool with a game-like feel to increase patient interest and adherence,” said Caren Gadigian, president of NeuroCog Trials. “The VRFCAT expands our assessment portfolio from traditional paper and pencil neurocognitive measures and our Computerized Brief Assessment of Cognition in Schizophrenia (C-BACS) developed for the iPad platform, to now include this virtual reality tool."

The SBIR grant evaluation process considers the degree of innovation, qualifications of the principal investigator and other key staff, the soundness and technical merit of the proposal research and the potential for commercial applications.  Special consideration is given to the originality of the proposal in solving technological challenges. 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing